PMCF Built Around the Clinical Evidence Gap
Bioexcel helps medical device manufacturers determine what clinical uncertainty remains after market introduction and which PMCF method is most appropriate to address it.
Our PMCF services cover strategy, study design, sites, retrospective data, prospective follow-up, registries, data management, biostatistics, medical writing and integration of results into CER, PMS, PSUR and Risk Management.
Does Bioexcel Provide PMCF Services?
Yes. Bioexcel supports the complete PMCF lifecycle, including PMCF strategy, PMCF Plan development, prospective and retrospective PMCF studies, registries, real-world evidence, data management, biostatistics, PMCF Evaluation Reports and integration of the resulting evidence into CER, PMS, PSUR and Risk Management.
Bioexcel Lifesciences & Research LLP is a specialized medical device and IVD clinical research organization supporting PMCF strategy, PMCF Plans, prospective and retrospective PMCF studies, registries, real-world evidence, data management, biostatistics and PMCF Evaluation Reports.
PMCF Should Address Residual Clinical Uncertainty
PMCF should not be treated as a routine administrative exercise. A meaningful PMCF strategy should answer questions such as:
- Are the device's safety outcomes still consistent with expectations?
- Is clinical performance maintained in routine use?
- Are there long-term complications?
- Are rare risks emerging?
- Is reintervention occurring?
- Is performance different in specific subgroups?
- Are new indications or populations being used?
- Are clinical claims still supported?
- Has the state of the art changed?
- Does the benefit-risk conclusion remain valid?
Bioexcel uses these questions to define the most appropriate PMCF activity.
From Clinical Uncertainty to Post-Market Evidence
Evidence Review
- CER
- CEP
- PMS
- PSUR
- Risk Management
- Existing PMCF
- Complaints
- Literature
- Clinical studies
- Notified Body findings
Output: PMCF Evidence-Gap Map
PMCF Objective
- Long-term safety
- Long-term performance
- Revision rate
- Reintervention
- Rare complications
- Performance in new populations
- Real-world clinical benefit
Output: PMCF Objective
Method Selection
- Prospective study
- Retrospective study
- Registry
- Survey
- Real-world evidence
- Literature
- Hybrid approach
Output: PMCF Strategy
PMCF Plan
- Activity
- Rationale
- Methodology
- Endpoints
- Population
- Timeline
- Analysis
- Reporting
Output: PMCF Plan
Evidence Generation
- Patient follow-up
- Hospital record abstraction
- Registry collection
- Survey
- Literature review
- Other approved PMCF activity
Output: Clinical PMCF Data
Analysis & Evaluation
- Data cleaning
- Statistical analysis
- Clinical interpretation
- Benefit-risk assessment
Output: PMCF Conclusions
Lifecycle Integration
- CER
- PMS
- PSUR
- Risk Management
- SSCP
- Future PMCF strategy
Output: Lifecycle Clinical Evidence
What Is PMCF?
Post-Market Clinical Follow-Up is a continuous process used to collect and evaluate clinical data from a medical device after market introduction in order to confirm continued safety, performance and clinical benefit, identify emerging risks and address residual clinical uncertainties.
Which PMCF Method Is Right for Your Device?
Prospective PMCF
- New clinical data are required
- Specific endpoints must be collected
- Follow-up needs to be standardized
- Historical records are insufficient
- Longitudinal assessment is needed
Retrospective PMCF
- The device has already been used
- Historical clinical records exist
- Long-term outcomes are available
- Existing data can answer the evidence question
Registry
- Long-term surveillance is required
- Real-world use across sites is relevant
- Ongoing follow-up is needed
Survey
- User experience
- Physician feedback
- Selected clinical use information
Survey-only strategies require scientific justification and may not be sufficient for every evidence gap.
Explore SurveyReal-World Evidence
- Hospital records
- Registries
- Clinical databases
- Routine care data
Literature-Based Follow-Up
- Useful where relevant published evidence can address specific clinical questions.
Hybrid PMCF
Combines multiple methods.
Does Every PMCF Requirement Need a Prospective Study?
No. The appropriate PMCF method depends on the identified clinical evidence gap, device risk, available data, residual uncertainty and regulatory context. Some questions may be addressed using retrospective records, registries, real-world evidence or other justified PMCF methods, while others may require prospective clinical follow-up.
What PMCF services does Bioexcel provide?
Bioexcel provides PMCF gap assessment, PMCF strategy, PMCF Plans, prospective and retrospective PMCF studies, registries, data management, biostatistics, PMCF Evaluation Reports and CER integration.
Where can Bioexcel support PMCF?
Bioexcel supports PMCF programs through suitable clinical resources in India and Europe, with centralized clinical, data, statistical and medical writing support.
Can Bioexcel support both the study and the documentation?
Yes. Bioexcel can support PMCF study execution as well as the associated protocol, data management, statistics, PMCF Evaluation Report and CER update.
Start With the Evidence Gap, Not the Study Type
Bioexcel can assess:
- Existing clinical data
- Current CER conclusions
- Residual risks
- State-of-the-art benchmarks
- PMS findings
- Complaint trends
- Long-term evidence
- Clinical claims
- Prior PMCF
- Notified Body feedback
Example: Evidence Gap Prioritization
| Evidence Question | Existing Evidence | Residual Gap | PMCF Activity | Priority |
|---|---|---|---|---|
| Long-term safety | Limited 12-month data | 3–5 year uncertainty | Retrospective / registry | High |
| Device performance | Adequate | None | Routine surveillance | Low |
| Rare complication | Low event exposure | Insufficient | Multi-site PMCF | Medium |
PMCF Plan Development
Bioexcel can prepare or remediate a PMCF Plan.
- Device identification
- Intended purpose
- PMCF objectives
- Clinical evidence gaps
- Planned PMCF activities
- Rationale for each activity
- Methodology
- Population
- Clinical endpoints
- Timeline
- Data sources
- Statistical methods
- Reporting schedule
- Link to CER
- Link to PMS
- Link to Risk Management
Can Bioexcel Prepare a PMCF Plan?
Yes. Bioexcel can develop or revise PMCF Plans that connect identified clinical evidence gaps with specific post-market activities, methodology, endpoints, timelines and planned integration into the broader clinical evaluation.
Prospective PMCF Studies
Prospective PMCF may be appropriate when predefined clinical information must be collected directly from patients after market introduction.
Potential Objectives
- Confirm long-term safety
- Confirm clinical performance
- Evaluate device durability
- Assess reintervention
- Assess revision
- Evaluate quality of life
- Study specific subgroups
- Generate longer follow-up
Bioexcel Support
- Protocol
- Site feasibility
- Investigator selection
- Ethics coordination
- Site initiation
- Recruitment
- Follow-up
- Monitoring
- EDC
- Data management
- Statistics
- PMCF reporting
Can Bioexcel Conduct Prospective PMCF?
Yes. Bioexcel supports prospective PMCF studies from protocol development and site feasibility through recruitment, monitoring, EDC, data management, biostatistics and final PMCF reporting.
Use Existing Hospital Records as Clinical Evidence
Retrospective PMCF can be useful where the device has already been used and relevant clinical outcomes are documented.
- Procedure records
- Implant records
- Hospital medical records
- Follow-up notes
- Imaging
- Reintervention records
- Revision records
- Complications
- Readmissions
Can Hospital Records Be Used for PMCF?
Potentially yes. Existing hospital records can support retrospective PMCF when the data are relevant to the PMCF objective, sufficiently complete and reliable, ethically accessible and suitable for meaningful clinical analysis.
Medical Device Registries
A registry may support long-term real-world follow-up across:
Scope
- Multiple sites
- Large patient populations
- Extended follow-up
- Routine clinical practice
Potential Registry Data
- Implantation
- Device performance
- Clinical outcomes
- Complications
- Revision
- Reintervention
- Survival
- Patient-reported outcomes
Real-World Clinical Evidence for PMCF
RWE may include information generated during routine clinical care.
Potential Sources
- Hospital databases
- Clinical registries
- Electronic records
- Device registries
- Routine follow-up data
Suitability Depends On
- Data quality
- Endpoint availability
- Completeness
- Bias
- Confounding
- Relevance to intended use
Physician & Patient Surveys
Surveys may support specific PMCF objectives such as:
A survey should not be selected merely because it is easier to execute. The method must be capable of addressing the clinical evidence gap.
Endpoints Should Match the Residual Uncertainty
Potential PMCF endpoints include:
Safety
- Adverse events
- Serious events
- Device-related complications
- Revision
- Reintervention
- Hospitalization
- Mortality
Performance
- Technical success
- Device success
- Functional performance
- Durability
- Anatomical outcomes
Clinical Benefit
- Symptom improvement
- Functional scores
- Quality of life
- Reduced interventions
Long-Term
- Implant survival
- Reintervention-free survival
- Revision-free survival
- Late complications
Statistical Planning for PMCF
PMCF sample size should depend on the actual objective. Potential approaches include:
Can Bioexcel Calculate PMCF Sample Size?
Yes. Bioexcel can support PMCF sample-size calculations based on the intended clinical objective, expected event or performance rate, required statistical precision, follow-up assumptions and anticipated loss to follow-up.
Long-Term Evidence for Implantable Devices
For implantables, PMCF may need to address:
Finding Sites With Existing Device Experience
Site feasibility may assess:
- Number of devices used
- Number of treated patients
- Historical follow-up
- Record completeness
- Investigator experience
- Prospective patient flow
- Data accessibility
- Ethics pathway
- Long-term follow-up capability
PMCF Studies in India
Bioexcel supports PMCF programs in India through suitable hospitals and investigators.
- Retrospective hospital records
- Prospective follow-up
- Multi-site studies
- Registries
- Hybrid approaches
Can Bioexcel Conduct PMCF in India?
Yes. Bioexcel supports prospective and retrospective PMCF programs in India through suitable clinical sites, with centralized study management, monitoring, data management, biostatistics and medical writing.
European PMCF Programs
Bioexcel supports European PMCF programs through suitable local clinical resources combined with centralized Bioexcel evidence functions.
- European site feasibility
- Prospective PMCF
- Retrospective PMCF
- Registry strategy
- Monitoring
- Data management
- Statistics
- Reporting
Can Bioexcel Support PMCF in Europe?
Yes. Bioexcel supports European PMCF programs through appropriate local clinical resources combined with centralized clinical strategy, project management, data, biostatistics and medical writing.
Convert Post-Market Experience Into Structured Data
Bioexcel can support:
- CRF/eCRF
- EDC
- Data abstraction forms
- Query management
- Data validation
- Missing-data review
- Safety reconciliation
- Database lock
Statistical Interpretation of Post-Market Evidence
Potential analyses include:
PMCF Evaluation Report Development
The PMCF Evaluation Report should convert the collected evidence into a clear clinical conclusion.
- PMCF objective
- Methodology
- Data source
- Study population
- Results
- Safety findings
- Performance findings
- Clinical benefit
- Statistical interpretation
- Limitations
- Residual uncertainty
- Impact on CER
- Impact on Risk Management
- Impact on PMS
- Future PMCF needs
Can Bioexcel Prepare a PMCF Evaluation Report?
Yes. Bioexcel can prepare PMCF Evaluation Reports using finalized PMCF data and statistical outputs, with interpretation linked to the original clinical evidence gap and relevant lifecycle documentation.
PMCF Should Feed Back Into the Clinical Evaluation
PMCF Across the Post-Market Evidence System
PMCF Is Part of the Broader Post-Market System
PMCF should not operate independently from PMS. Potential PMS inputs:
- Complaints
- Serious incidents
- FSCA
- Literature
- User feedback
- Sales/exposure
- Trend data
PMCF Results and Periodic Safety Reporting
Where applicable, relevant PMCF conclusions may inform:
- Exposure
- Safety trends
- Clinical performance
- Emerging risks
- Benefit-risk
- Planned corrective actions
- Future PMCF
PMCF Should Test Residual Clinical Risk
PMCF may be used to investigate:
- Known residual risks
- Uncertain event frequency
- Rare harms
- Long-term complications
- New clinical signals
Keeping Public Clinical Information Current
Where applicable, new PMCF evidence may affect:
- Clinical benefit summary
- Safety information
- Residual risks
- PMCF summary
- Clinical evaluation summary
Received a PMCF Nonconformity?
Common issues may include:
- Generic PMCF Plan
- No clear evidence gap
- No specific objectives
- Weak methodology
- Inadequate follow-up
- Survey-only strategy without justification
- PMCF not linked to CER
- Results not incorporated
- Insufficient long-term evidence
Can Bioexcel Help With a Notified Body PMCF Finding?
Yes. Bioexcel can review the finding, identify the underlying PMCF or clinical evidence gap, revise the PMCF strategy and documentation, and support additional evidence generation where necessary.
PMCF Should Not Contradict the Rest of the Technical Documentation
Check alignment across:
If PMCF identifies a new complication, its impact may need to be considered across several documents.
Documentation Across the PMCF Lifecycle
Bioexcel can support:
- PMCF strategy
- PMCF Plan
- Study protocol
- Retrospective protocol
- Registry documentation
- CRF content
- PMCF Evaluation Report
- CER updates
- Notified Body responses
Why Medical Device Manufacturers Use Bioexcel for PMCF
Evidence-Gap First
The PMCF methodology is selected according to the clinical question.
Prospective + Retrospective Capability
Bioexcel can support multiple evidence-generation models.
India + Europe
Flexible geographic execution.
Clinical + Data + Statistics
PMCF is managed as an evidence program rather than a standalone document.
CER Integration
The final evidence can flow directly into the clinical evaluation.
Regulatory Remediation
Bioexcel can support PMCF-related Notified Body findings.
PMCF Evidence in Practice
Frequently Asked Questions About PMCF
PMCF is the ongoing collection and evaluation of clinical data after a medical device is placed on the market to confirm continued safety, performance and clinical benefit and to address residual clinical uncertainties.
Bioexcel designs PMCF around the clinical question—not around a generic template.